ENLIVEN THERAPEUTICS INC (ELVN:NASDAQ)
$40.61 -0.8 (-1.9319%)
Analysed ENLIVEN THERAPEUTICS INC (ELVN:NASDAQ) News Sources
Enliven Therapeutics (ELVN) Soars to 5-Year High as Analysts ‘Upbeat’
26-03-2026
yahoo.com
Enliven Theraeutics' (ELVN) Chief Medical Officer Sold 40,000 Shares for $1.2 Million
28-03-2026
fool.com
Assessing Enliven Therapeutics (ELVN) Valuation After Strong Recent Share Price Momentum
30-03-2026
yahoo.com
Enliven (ELVN) Gets Higher Price Targets From H.C. Wainwright and Mizuho
06-04-2026
yahoo.com
Enliven Therapeutics (ELVN) Up 194% This Year on Strong CML Market
17-04-2026
yahoo.com
Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update
07-05-2026
yahoo.com
Why is Enliven Therapeutics (ELVN) One of the Best Performing Healthcare Stocks so Far in 2026?
10-05-2026
yahoo.com
Enliven Therapeutics Announces Oral Presentation at the EHA 2026 Congress Featuring Additional Positive Phase 1 Clinical Trial Data for ELVN-001 in CML
12-05-2026
yahoo.com
Why This Biotech Fund Added $7 Million to an Oncology Stock Up 120%
13-05-2026
fool.com
Enliven Therapeutics to Present at Upcoming Investor Conferences
21-05-2026
yahoo.com
What is the current price of ENLIVEN THERAPEUTICS INC (ELVN:NASDAQ)?
The current price of ENLIVEN THERAPEUTICS INC (ELVN:NASDAQ) is $40.61.
ENLIVEN THERAPEUTICS INC (ELVN:NASDAQ) absolute price change since previous trading day?
The absolute price change of ENLIVEN THERAPEUTICS INC (ELVN:NASDAQ) since the previous trading day is $-0.8.
ENLIVEN THERAPEUTICS INC (ELVN:NASDAQ) percentage price change since previous trading day?
The percentage price change of ENLIVEN THERAPEUTICS INC (ELVN:NASDAQ) since the previous trading day is -1.9319%.
What is the most recent average sentiment score for ENLIVEN THERAPEUTICS INC (ELVN:NASDAQ)?
The most recent average sentiment score for ENLIVEN THERAPEUTICS INC (ELVN:NASDAQ) is 90 out of 100.
What is the most recent average sentiment for ENLIVEN THERAPEUTICS INC (ELVN:NASDAQ)?
The most recent sentiment for ENLIVEN THERAPEUTICS INC (ELVN:NASDAQ) is .
SEC-8K** Filing Available For ENLIVEN THERAPEUTICS INC (ELVN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.